Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Azathioprine may help treat severe alopecia areata, but more research is needed.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

PRP more effective than minoxidil 5% for treating alopecia areata.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.